An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10–17 years of age

Autor: Poder, Airi, Simurka, Pavol, Li, Ping, Roy-Ghanta, Sumita, Vaughn, David
Zdroj: In Vaccine 19 February 2014 32(9):1121-1129
Databáze: ScienceDirect